Medicalsystem Biotechnology Co., Ltd (SHE:300439)
China · Delayed Price · Currency is CNY 10.25
+0.10 (0.99%)
Feb 4, 2026, 3:04 PM CST
SHE:300439 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 94.17 | 258 | 256.55 | 198.53 | 179.49 | 299.48 |
Depreciation & Amortization | 205.51 | 205.51 | 169.63 | 191.67 | 194.82 | 173.52 |
Other Amortization | 17.35 | 17.35 | 15.11 | 19.97 | 33.12 | 32.7 |
Loss (Gain) From Sale of Assets | 0.67 | 0.67 | 0.78 | 0.32 | -0.48 | -3.22 |
Asset Writedown & Restructuring Costs | 2.12 | 2.12 | 10.87 | 13.1 | 4.03 | 6.78 |
Loss (Gain) From Sale of Investments | -3.26 | -3.26 | -11.33 | 5.98 | 15.98 | 38.57 |
Provision & Write-off of Bad Debts | -19.73 | -19.73 | -4.28 | 40.98 | 21.85 | 1.67 |
Other Operating Activities | 214.95 | 15.18 | -6.86 | 41.69 | 48.81 | 47.79 |
Change in Accounts Receivable | 16.71 | 16.71 | 206.66 | -76.76 | -147.18 | 372.35 |
Change in Inventory | -33.6 | -33.6 | -58.02 | -20.71 | 15.31 | 81.77 |
Change in Accounts Payable | -67.18 | -67.18 | 34.98 | 179.33 | 159.07 | 2.38 |
Change in Other Net Operating Assets | 13.33 | 13.33 | 16.57 | -19.2 | -0.73 | -181.21 |
Operating Cash Flow | 433.75 | 397.81 | 633.53 | 564.67 | 515.48 | 912.07 |
Operating Cash Flow Growth | 17.61% | -37.21% | 12.20% | 9.54% | -43.48% | 51.72% |
Capital Expenditures | -318.06 | -420.54 | -280.37 | -303.13 | -201.82 | -383.43 |
Sale of Property, Plant & Equipment | 34.38 | 34.32 | 23.45 | 7.31 | 27.13 | 26.46 |
Cash Acquisitions | 0.67 | - | - | - | - | -17.79 |
Divestitures | 6.36 | 23.97 | 63.66 | 33.55 | 5.2 | 31.21 |
Investment in Securities | -12.48 | -168.77 | 18.81 | 21.13 | -47.35 | 9.23 |
Other Investing Activities | 5.43 | 3.91 | 12.38 | 8.66 | 29.27 | 81.31 |
Investing Cash Flow | -283.71 | -527.11 | -162.08 | -232.49 | -187.56 | -253.02 |
Short-Term Debt Issued | - | 30 | 50 | - | 1.5 | - |
Long-Term Debt Issued | - | - | - | 212.65 | 410.95 | 1,002 |
Total Debt Issued | - | 30 | 50 | 212.65 | 412.45 | 1,002 |
Short-Term Debt Repaid | - | -57.04 | -278.04 | - | -1.5 | -0.39 |
Long-Term Debt Repaid | - | -16.84 | -18.57 | -383.19 | -883.43 | -1,624 |
Total Debt Repaid | -46.84 | -73.88 | -296.61 | -383.19 | -884.93 | -1,624 |
Net Debt Issued (Repaid) | -46.84 | -43.88 | -246.61 | -170.55 | -472.49 | -621.87 |
Issuance of Common Stock | - | - | - | - | 586.6 | - |
Repurchase of Common Stock | - | - | - | - | - | -27.88 |
Common Dividends Paid | -52.42 | -52.47 | -49.88 | -50.71 | -91.39 | -125.37 |
Other Financing Activities | -9.56 | -0.06 | -7.04 | 0.18 | 1.47 | 0.86 |
Financing Cash Flow | -108.82 | -96.42 | -303.52 | -221.07 | 24.2 | -774.26 |
Foreign Exchange Rate Adjustments | -1.63 | 0.01 | 0.54 | -1.58 | 0.93 | -0.1 |
Net Cash Flow | 39.58 | -225.71 | 168.47 | 109.52 | 353.06 | -115.31 |
Free Cash Flow | 115.69 | -22.73 | 353.16 | 261.53 | 313.67 | 528.64 |
Free Cash Flow Growth | -8.72% | - | 35.04% | -16.62% | -40.66% | 122.15% |
Free Cash Flow Margin | 7.86% | -1.30% | 18.73% | 10.51% | 13.93% | 22.96% |
Free Cash Flow Per Share | 0.30 | -0.06 | 0.92 | 0.69 | 0.84 | 1.53 |
Cash Income Tax Paid | 87.31 | 98.26 | 132.25 | 129.64 | 128.04 | 107.74 |
Levered Free Cash Flow | -69.88 | -46.86 | 238.63 | 138.27 | 245.86 | 167.89 |
Unlevered Free Cash Flow | -68.53 | -45.28 | 245.29 | 148.04 | 264.15 | 202.35 |
Change in Working Capital | -78.02 | -78.02 | 203.05 | 52.41 | 17.87 | 314.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.